Earnings NewsHealthcareOsiris Therapeutics beats by $0.04, beats on revenueMay 08, 2015 8:01 AM ETOsiris Therapeutics, Inc. (OSIR) StockBy: SA News Team Osiris Therapeutics (NASDAQ:OSIR): Q1 EPS of $0.04 beats by $0.04. Revenue of $21M (+109.0% Y/Y) beats by $2.6M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgOSIR--Osiris Therapeutics, Inc.Trending AnalysisTrending News